WebMD ad trends remain strong, says Stifel After evaluating ad trends, Stifel remains upbeat about WebMD's Q3 and Q4 outlook. The firm thinks that investors' concerns regarding the transition to mobile and the company's recent tender offer are overblown. It keeps a Buy rating on the stock.
News For WBMD From The Last 14 Days
Check below for free stories on WBMD the last two weeks.
WebMD momentum positive, says Stifel Stifel believes that WebMD continues to benefit from positive advertising momentum, as capacity levels so far this quarter appear to be in-line with Q2 levels. The firm thinks the company's initiatives will improve its performance further, and it keeps a Buy rating on the stock.